Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT C GALAGAN

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1538253901
CMS profile
342168
Location
NEW ORLEANS, LA

General Payments · PY2018–2024

$735.39

  • Reported across 44 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$311.30

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $311.30 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $67.48 4
Corcept Therapeutics $49.34 3
Amgen Inc. $46.57 2
SANOFI-AVENTIS U.S. LLC $43.97 2
Novo Nordisk AS $32.84 2
DEXCOM, INC. $28.33 1
Xeris Pharmaceuticals, Inc. $25.51 1
Ascendis Pharma Inc $17.26 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $35.06 3
PY2019 $95.49 6
PY2023 $293.54 19
PY2024 $311.30 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $29.10 06/05/2024 Food and Beverage Undisputed 01/23/2026 1115641714 CMS
Amgen Inc. $17.47 09/25/2024 Food and Beverage Undisputed 01/23/2026 1115641722 CMS
Ascendis Pharma Inc $17.26 12/04/2024 Food and Beverage Undisputed 01/23/2026 1133850886 CMS
Corcept Therapeutics $16.51 06/12/2024 Food and Beverage Undisputed 01/23/2026 1117747685 CMS
Corcept Therapeutics $16.38 07/24/2024 Food and Beverage Undisputed 01/23/2026 1117747693 CMS
Corcept Therapeutics $16.45 12/12/2024 Food and Beverage Undisputed 01/23/2026 1117747743 CMS
Dexcom, Inc. $28.33 11/13/2024 Food and Beverage Undisputed 01/23/2026 1153331393 CMS
Novo Nordisk Inc $14.10 01/03/2024 Food and Beverage Undisputed 01/23/2026 1096850414 CMS
Novo Nordisk Inc $18.74 02/21/2024 Food and Beverage Undisputed 01/23/2026 1097111287 CMS
PFIZER INC. $19.00 04/11/2024 Food and Beverage Undisputed 01/23/2026 1131335441 CMS
PFIZER INC. $13.45 04/17/2024 Food and Beverage Undisputed 01/23/2026 1131381749 CMS
PFIZER INC. $19.55 09/18/2024 Food and Beverage Undisputed 01/23/2026 1131977823 CMS
PFIZER INC. $15.48 10/14/2024 Food and Beverage Undisputed 01/23/2026 1132118548 CMS
SANOFI-AVENTIS U.S. LLC $22.79 03/27/2024 Food and Beverage Undisputed 01/23/2026 1139711156 CMS
SANOFI-AVENTIS U.S. LLC $21.18 11/06/2024 Food and Beverage Undisputed 01/23/2026 1139711284 CMS
Xeris Pharmaceuticals, Inc. $25.51 05/08/2024 Food and Beverage Undisputed 01/23/2026 1144610876 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.